Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Muscadine Products Corporation is a specialized nutraceutical company focused on the processing and extraction of bioactive compounds from muscadine grapes. Based in Georgia, the company leverages proprietary cold-press and dehydration technologies to produce high-quality seed and skin powders, juices, and concentrates. These products are rich in polyphenols, including resveratrol, ellagic acid, and quercetin, which are targeted for their antioxidant and anti-inflammatory properties. MPC serves as a primary ingredient supplier for the dietary supplement, functional food, and cosmetic industries. The company's ingredients have been utilized in various academic clinical studies investigating cardiovascular health and oncology support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Muscadine Products Corporation.